Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Psychopharmacology (Berl) ; 233(10): 1889-99, 2016 05.
Artículo en Inglés | MEDLINE | ID: mdl-26809457

RESUMEN

RATIONALE: Several lines of recent evidence suggest that endocannabinoids affect behavior by influencing the general patterns of challenge responding. OBJECTIVES: Here, we investigated the brain mechanisms underlying this phenomenon in rats. METHODS: The anandamide hydrolysis inhibitor URB597 was condensed into the tip of stainless steel cannulae, which were chronically implanted slightly above the prelimbic cortex (PRL) or the basolateral amygdala (BLA), two important regions of coping and endocannabinoid action. Thereafter, we investigated behavioral responsiveness to ambient light level in the elevated plus-maze and conditioned fear tests. RESULTS: URB597 concentration was ~30 µg/mg protein in target areas; local brain anandamide levels increased threefold, without significant changes in 2-arachidonoylglycerol. High levels of illumination halved the time spent by controls in the open arms of the plus-maze. No similar decrease was observed in rats with URB597 implants in the PRL. High light decreased conditioned fear by 30 % in controls, but not in rats with prelimbic URB597 implants. Unresponsiveness to environmental challenges was not attributable to the anxiolytic effects of anandamide enhancement, as implants induced paradoxical anxiogenic-like effects under low light, which could be explained by effects on stimulus responsiveness rather than by effects on anxiety. URB597 implants targeting the BLA did not affect stimulus responsiveness. CONCLUSIONS: Our findings show that elevated prelimbic anandamide signaling leads to less environment-dependent (more autonomous) behavioral responses to challenges, which is an attribute of active coping styles. These findings are discussed in light of two emerging concepts of endocannabinoid roles, particularly "emotional homeostasis" and "active coping."


Asunto(s)
Adaptación Psicológica/fisiología , Ácidos Araquidónicos/metabolismo , Complejo Nuclear Basolateral/metabolismo , Benzamidas/farmacología , Carbamatos/farmacología , Endocannabinoides/metabolismo , Alcamidas Poliinsaturadas/metabolismo , Corteza Prefrontal/metabolismo , Adaptación Psicológica/efectos de los fármacos , Animales , Ansiolíticos/farmacología , Ansiedad/tratamiento farmacológico , Ansiedad/metabolismo , Complejo Nuclear Basolateral/efectos de los fármacos , Glicéridos/metabolismo , Masculino , Corteza Prefrontal/efectos de los fármacos , Ratas , Ratas Wistar , Transducción de Señal/efectos de los fármacos
2.
Regul Pept ; 157(1-3): 1-2, 2009 Oct 09.
Artículo en Inglés | MEDLINE | ID: mdl-19540879

RESUMEN

BACKGROUND AND AIMS: The gene(s) encoding for endomorphin precursor(s) is/are still unknown. We have raised the possibility of and did find some evidence for a potential de novo biosynthetic route starting from Tyr-Pro precursor. To pursue further this possibility we measured the generation of immunoreactive endomorphin-2 (E2-IR) in adult rat isolated L4,5 dorsal root ganglia. RESULTS AND CONCLUSIONS: In rat isolated dorsal root ganglia the combination of presumed biosynthetic precursor of endomorphin 2 (E2), Tyr-Pro with the dipeptidyl peptidase IV (DPP-IV) inhibitor Ile-Pro-Ile generated 1.60+/-0.37 pg/mg Wet Tissue Weight_30 min E2-IR in the bathing fluid (n=4) with an 8-fold increase upon depolarization whereas the tissue content was low (0.50+/-0.08 pg/mg_WTW). Substance P, as determined by ELISA in the pilot experiments, was found almost exclusively within the tissues. It is concluded that E2-IR was generated extracellularly by a membrane-bound DPP-IV, which was switched to "synthase" mode by the hydrolase inhibitor Ile-Pro-Ile. DPP-IV was depolarization-sensitive in "synthase" functional mode.


Asunto(s)
Dipeptidil Peptidasa 4/metabolismo , Ganglios Espinales/metabolismo , Oligopéptidos/inmunología , Animales , Membrana Celular/metabolismo , Inhibidores de la Dipeptidil-Peptidasa IV , Oligopéptidos/farmacología , Proyectos Piloto , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA